Computer Modeling of Selective Regions in the Active Site of Nitric Oxide Synthases: Implication for the Design of Isoform-Selective Inhibitors
- 22 November 2003
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 46 (26) , 5700-5711
- https://doi.org/10.1021/jm030301u
Abstract
Selective inhibition of nitric oxide synthase (NOS) isoforms has great therapeutic potential in the treatment of certain disease states arising from the pathological overproduction of nitric oxide. In this study three structures of each NOS isoform were employed to examine selective regions in the active site using the GRID/CPCA approach. In the GRID calculations, 10 probes covering hydrophobic, steric, and hydrogen-bond-acceptor and -donor interactions were used to calculate the molecular interaction fields (MIFs) in the active site. The side chain flexibility of the residues and the grid spacings were considered at the same time. Consensus principal component analysis (CPCA) was applied to analyze the MIFs differences in the active site between the NOS isoforms. By combining the cutout tool with GRID/CPCA pseudofield differential plots, several selective regions in the active site were identified. The selectivity analysis showed that the most important determinants for NOS inhibitor selectivity are hydrophobic and charge−charge interactions. Twenty-five inhibitors of NOS were then docked into the active site using the program AutoDock3.0. The regions identified as being important for selectivity by this method are in excellent agreement with inhibitor structure−activity relationships. A rational usage of the selective region described in this work should make it possible to develop NOS isoform-selective inhibitors.Keywords
This publication has 35 references indexed in Scilit:
- Efficient docking of peptides to proteins without prior knowledge of the binding siteProtein Science, 2002
- Structural Basis for Pterin Antagonism in Nitric-oxide SynthaseJournal of Biological Chemistry, 2001
- Implications for Isoform-selective Inhibitor Design Derived from the Binding Mode of Bulky Isothioureas to the Heme Domain of Endothelial Nitric-oxide SynthaseJournal of Biological Chemistry, 2001
- INHIBITION OF NITRIC OXIDE SYNTHASE AS A POTENTIAL THERAPEUTIC TARGETAnnual Review of Pharmacology and Toxicology, 1999
- Crystal Structure of Constitutive Endothelial Nitric Oxide Synthase: A Paradigm for Pterin Function Involving a Novel Metal CenterCell, 1998
- 2-Iminopyrrolidines as Potent and Selective Inhibitors of Human Inducible Nitric Oxide SynthaseJournal of Medicinal Chemistry, 1998
- The Structure of Nitric Oxide Synthase Oxygenase Domain and Inhibitor ComplexesScience, 1997
- Hypertension in mice lacking the gene for endothelial nitric oxide synthaseNature, 1995
- Cloned human brain nitric oxide synthase is highly expressed in skeletal muscleFEBS Letters, 1993
- Biosynthetic origin of the carbon skeleton and oxygen atoms of nargenicin A1Journal of the American Chemical Society, 1984